Nucl Med Mol Imaging.  2015 Mar;49(1):57-60. 10.1007/s13139-014-0297-x.

Metastatic Neuroendocrine Tumour in a Renal Transplant Recipient: Dual-Tracer PET-CT with 18F-FDG and 68Ga-DOTANOC in This Rare Setting

Affiliations
  • 1Department of Nuclear Medicine, All India Institute of Medical Sciences, E-81, Ansari Nagar (East) AIIMS Campus, New Delhi 110029, India. rkphulia@yahoo.com
  • 2Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.

Abstract

Recipients of renal transplant are at increased risk of developing various malignancies, especially post-transplant lymphoproliferative disorder (PTLD) and skin cancers. Neuroendocrine tumours (NET) of the gastrointestinal tract have not been reported in this setting. Here we describe the case of a 75-year-old male who had undergone renal transplant 8 years back and now presented with significant weight loss and backache, clinically suspected as PTLD. 18F-Fluordeoxyglucose (18F-FDG) positron emission tomography-computed tomography (PET-CT) showed hypermetabolic lesions in the liver and rectum, raising the suspicion of PTLD. However, biopsy from the liver lesion showed poorly differentiated NET. 68Ga-labelled [1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid]-1-NaI3-octreotide (68Ga-DOTANOC) PET-CT was then done, which confirmed the primary lesion in the rectum with liver metastases.

Keyword

Neuroendocrine tumour; PET-CT; 68Ga-DOTANOC; 18F-FDG; Post-transplant lymphoproliferative disorder

MeSH Terms

Aged
Back Pain
Biopsy
Electrons
Fluorodeoxyglucose F18*
Gastrointestinal Tract
Humans
Liver
Lymphoproliferative Disorders
Male
Neoplasm Metastasis
Rectum
Skin Neoplasms
Transplantation*
Weight Loss
Fluorodeoxyglucose F18
Full Text Links
  • NMMI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr